Ren S M, Long L Y, Xu C S
National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Graduate School of Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Apr 18;52(2):214-220. doi: 10.19723/j.issn.1671-167X.2020.02.004.
To identify the chaperone of polypyrimidine tractor-binding protein-associated splicing factor (PSF) in myeloid leukemia cells, and to explore the mechanism and redistributive pattern to cell surface of PSF in chemo-sensitive HL60 cells and resistant HL60/DOX cells.
The eukaryotic expression vector of PSF was transfected with liposomes transiently, then flow cytometry was used to detect the expression level of PSF on the cell surface 24 h, 48 h and 72 h after vector transfections. We constructed a chimeric expression vector, streptavidin binding peptide (SBP)-PSF, meanwhile this vector was transfected and made SBP-PSF fusion protein overexpress. In addition, we used streptavidin magnetic beads to precipitate the cellular chaperonin of PSF and then identified its chaperonin by mass spectrometry (MS). Lentiviral vectors containing cytokeratin18 (K18) interference sequences were transfected into 293T cells to prepare lentivirus. HL60 and HL60/DOX cells were infected with lentivirus to obtain stable interfering K18 cell lines. Next, flow cytometry was used to test the membrane relocation level of PSF. Together, these methods confirmed the similar or different mechanisms of the PSF redistributing to membrane synergistically mediated by K18 in HL60 and HL60/DOX cells.
The expression of membrane relocated PSF was detected every day for three days (at the end of 24 h, 48 h and 72 h) after transient overexpression. The expressing rate of PSF on the cell surface was 22.4%±3.5%, 37.9%±6.0%, 58.3%±8.8%, respectively in sensitive HL60 cells, while that was 4.7%±0.5%, 3.9%±0.6%, 2.9%±0.6% , respectively in resistant HL60/DOX cells. The difference of expressing rate on each day was significant, P<0.01. We identified K18 detected by co-immunoprecipitation and mass spectrum assay which was the cellular chaperone of PSF. We found that K18 knockdown decreased the PSF expression level which redistributed on cell surface from 48.9%±5.4% to 6.2%±1.0% in sensitive HL60 cells, and from 9.11%±1.2% to 2.21%±0.51% in resistant HL60/DOX cells, respectively.
K18 is the intracellular chaperonin of PSF. The interaction of PSF and K18 mediates its redistribution to cell membrane in sensitive cells. While in resistant cells, PSF failed to relocate at the cell surface and accumulated in cells, which mediated resistance to chemotherapeutics.
鉴定髓系白血病细胞中多嘧啶 tract 结合蛋白相关剪接因子(PSF)的伴侣蛋白,并探讨化疗敏感的 HL60 细胞和耐药的 HL60/DOX 细胞中 PSF 向细胞表面重分布的机制及模式。
采用脂质体瞬时转染 PSF 的真核表达载体,然后用流式细胞术检测转染载体后 24 小时、48 小时和 72 小时细胞表面 PSF 的表达水平。构建嵌合表达载体链霉亲和素结合肽(SBP)-PSF,同时转染该载体使 SBP-PSF 融合蛋白过表达。此外,用链霉亲和素磁珠沉淀 PSF 的细胞伴侣蛋白,然后通过质谱(MS)鉴定其伴侣蛋白。将含细胞角蛋白 18(K18)干扰序列的慢病毒载体转染至 293T 细胞制备慢病毒。用慢病毒感染 HL60 和 HL60/DOX 细胞以获得稳定干扰 K18 的细胞系。接下来,用流式细胞术检测 PSF 的膜重定位水平。这些方法共同证实了 K18 在 HL60 和 HL60/DOX 细胞中协同介导 PSF 向膜重分布的相似或不同机制。
瞬时过表达后连续三天每天检测膜重定位的 PSF 的表达情况(在 24 小时、48 小时和 72 小时末)。在敏感的 HL60 细胞中,PSF 在细胞表面的表达率分别为 22.4%±3.5%、37.9%±6.0%、58.3%±8.8%,而在耐药的 HL60/DOX 细胞中分别为 4.7%±0.5%、3.9%±0.6%、2.9%±0.6%。每天表达率的差异具有显著性,P<0.01。通过免疫共沉淀和质谱分析鉴定出 K18 是 PSF 的细胞伴侣蛋白。我们发现,在敏感的 HL60 细胞中,敲低 K18 使重分布到细胞表面的 PSF 表达水平从 48.9%±5.4%降至 6.2%±1.0%,在耐药的 HL60/DOX 细胞中从 9.11%±1.2%降至 2.21%±0.51%。
K18 是 PSF 的细胞内伴侣蛋白。PSF 与 K18 的相互作用介导其在敏感细胞中向细胞膜的重分布。而在耐药细胞中,PSF 未能在细胞表面重定位并在细胞内积累,这介导了对化疗药物的耐药性。